It is worth noting that BMPR2 expression in PBMCs was notably lower in PAH patients compared to healthy controls (n = 13; p = 0.005), but it increased following FK506 therapy [17]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.